Align Technology (ALGN)
(Delayed Data from NSDQ)
$212.15 USD
+1.37 (0.65%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $211.69 -0.46 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$212.15 USD
+1.37 (0.65%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $211.69 -0.46 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
Zacks News
5 MedTech Stocks to Gain in 2021 as Base Business Recovers
by Urmimala Biswas
These five MedTech stocks, EYE, MRVI, SONVY, SARTF and HSIC, all with a favorable Zacks Rank and growth parameters are expected to put up a robust performance in 2021.
Align Technology (ALGN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Align Technology (ALGN) closed at $585.50, marking a -0.72% move from the previous day.
Align Technology (ALGN) Launches New Features in iTero Family
by Zacks Equity Research
Align Technology's (ALGN) iTero Workflow 2.0 software and iTero Element 5D Imaging system auto-upload functionality to drive innovation in digital orthodontics and restorative dentistry.
Align Technology (ALGN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed the most recent trading day at $566.96, moving -1.48% from the previous trading session.
Why Is Align Technology (ALGN) Down 0.8% Since Last Earnings Report?
by Zacks Equity Research
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Henry Schein (HSIC) Software Module to Enhance Patient Outcome
by Zacks Equity Research
Henry Schein's (HSIC) latest software module is expected to provide better patient care and improved patient experience.
7 Inverse ETFs Riding High on Nasdaq Sell-Off
by Sweta Killa
We have highlighted seven inverse ETFs that benefited the most from the Nasdaq sell-off.
Stock Market News for May 11, 2021
by Zacks Equity Research
Benchmarks closed in the red on Monday as inflation jitters moved investors away from stocks sensitive to economic reopening
Align Technology (ALGN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed the most recent trading day at $582.15, moving -2.94% from the previous trading session.
XRAY vs. ALGN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
XRAY vs. ALGN: Which Stock Is the Better Value Option?
Align Technology (ALGN) Q1 Earnings Beat Estimates, Margins Up
by Zacks Equity Research
Align Technology's (ALGN) segments report solid Q1 sales across geographies despite the pandemic-led business challenges.
Align Technology (ALGN) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Align Technology (ALGN) delivered earnings and revenue surprises of 25.13% and 8.54%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Medical Product Stocks' Earnings on Apr 28: BSX, ALGN & More
by Urmimala Biswas
The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
Why the Earnings Surprise Streak Could Continue for Align Technology (ALGN)
by Zacks Equity Research
Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Align Technology (ALGN) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Align Technology (ALGN) is expected to have gained from robust Invisalign aligners and iTero scanners shipment volume in Q1.
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
by Zacks Equity Research
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
Intuitive Surgical (ISRG) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results reflect strong segmental performance.
Edwards Lifesciences (EW) Beats on Q1 Earnings, Margins Down
by Zacks Equity Research
Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed robust segmental performances in Q1.
Integra (IART) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Integra (IART) is optimistic about maintaining its strength in its international business, along with its portfolio optimization strategy.
Here's Why You Should Hold on to LabCorp (LH) Stock Now
by Zacks Equity Research
Investors are optimistic about LabCorp (LH) backed by its strong diagnostic arm growth and progress in Covance business.
Align Technology (ALGN) Stock Moves -0.43%: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $603.72 in the latest trading session, marking a -0.43% move from the prior day.
What Makes Align Technology (ALGN) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Align Technology (ALGN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (ALGN) Outperforming Other Medical Stocks This Year?
Align Technology's (ALGN) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Align Technology (ALGN).